Knight Therapeutics(KHTRF)
$8.43+0.02 (+0.18%)
KHTRF
Knight Therapeutics technical analysis
$8.43
At close:+0.02 (+0.18%)
Knight Therapeutics (KHTRF) Technical Analysis
33 Followers
Technical Sentiment
Overall ConsensusStrong Sell Strong Buy Strong Buy
3Bearish
4Neutral
15Bullish
Technical Analysis ConsensusStrong Sell Strong Buy Neutral
3Bearish
4Neutral
3Bullish
Moving Average ConsensusStrong Sell Strong Buy Strong Buy
0Bearish
0Neutral
12Bullish
1 Day timeframe · Data as of Nov 11, 2026
- Knight Therapeutics’s (KHTRF) Moving Averages Convergence Divergence (MACD) indicator is 0.21, suggesting Knight Therapeutics is a Sell.
- Knight Therapeutics’s (KHTRF) 20-Day exponential moving average is 8.08, while Knight Therapeutics’s (KHTRF) share price is $8.43, making it a Buy.
- Knight Therapeutics’s (KHTRF) 50-Day exponential moving average is 7.71, while Knight Therapeutics’s (KHTRF) share price is $8.43, making it a Buy.
Knight Therapeutics (KHTRF) Pivot Points
1 Day timeframe · Data as of Nov 11, 2026
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 8.38 | 8.40 | 8.40 | 8.42 | 8.42 | 8.44 | 8.44 |
| Fibonacci | 8.40 | 8.40 | 8.41 | 8.42 | 8.42 | 8.43 | 8.44 |
Knight Therapeutics (KHTRF) Moving Averages
1 Day timeframe · Data as of Nov 11, 2026
| Period | Simple | Exponential |
|---|---|---|
| MA5 | 8.32Buy | 8.32Buy |
| MA10 | 8.20Buy | 8.24Buy |
| MA20 | 8.12Buy | 8.08Buy |
| MA50 | 7.62Buy | 7.71Buy |
| MA100 | 7.26Buy | 7.25Buy |
| MA200 | 6.30Buy | 6.34Buy |
- Knight Therapeutics’s (KHTRF) 10-Day exponential moving average is 8.24, while Knight Therapeutics’s (KHTRF) share price is $8.43, making it a Buy.
- Knight Therapeutics’s (KHTRF) 100-Day exponential moving average is 7.25, while Knight Therapeutics’s (KHTRF) share price is $8.43, making it a Buy.
- Knight Therapeutics’s (KHTRF) stock price is $8.43 and Knight Therapeutics’s (KHTRF) 50-day simple moving average is 7.62, creating a Buy signal.
- Knight Therapeutics’s (KHTRF) stock price is $8.43 and Knight Therapeutics’s (KHTRF) 100-day simple moving average is 7.26, creating a Buy signal.
- Knight Therapeutics’s (KHTRF) stock price is $8.43 and Knight Therapeutics’s (KHTRF) 200-day simple moving average is 6.30, creating a Buy signal.
Knight Therapeutics (KHTRF) Technical Indicators
1 Day timeframe · Data as of Nov 11, 2026
| Name | Value | Implied Action |
|---|---|---|
| RSI (14) | 70.45 | Sell |
| STOCH (9,6) | 61.11 | Neutral |
| STOCHRSI (14) | 61.11 | Neutral |
| MACD (12,26) | 0.21 | Sell |
| ADX (14) | 31.29 | Neutral |
| Williams %R | -31.67 | Buy |
| CCI (14) | 124.07 | Sell |
| ATR (14) | 0.12 | - |
| Ultimate Oscillator | 43.69 | Neutral |
| ROC | 1.69 | Buy |
- Knight Therapeutics’s (KHTRF) Relative Strength Index (RSI) is 70.45, creating a Sell signal.
- Knight Therapeutics’s (KHTRF) Trend Strength Indicator (ADX) is 31.29, creating a Neutral signal.
- Knight Therapeutics’s (KHTRF) Commodity Channel Index (CCI) is 124.07, creating a Sell signal.
- Knight Therapeutics’s (KHTRF) Price Rate of Change (ROC) is 1.69, creating a Buy signal.
unique trading strategy with a flexible screenerTry it Now!
FAQ
Is KHTRF a Buy, Hold, or Sell?
Based on KHTRF’s technical indicators on the 1-day timeframe as of Nov 11, 2026, KHTRF is a Strong Buy.
What is KHTRF’s RSI (14)?
KHTRF’s RSI (14) is 70.45, which suggests KHTRF is a Sell.
What is KHTRF’s MACD?
KHTRF’s MACD is 0.21, which suggests KHTRF is a Sell.
What is KHTRF’s 5-day moving average?
KHTRF’s 5-day moving average is 8.32, which suggests KHTRF is a Buy.
What is KHTRF’s 20-day moving average?
KHTRF 20-day moving average is 8.12, which suggests KHTRF is a Buy.
What is KHTRF’s 50-day moving average?
KHTRF’s 50-day moving average is 7.62, which suggests KHTRF is a Buy.
What is KHTRF’s 200-day moving average?
KHTRF’s 200-day moving average is 6.30, which suggests KHTRF is a Buy.
What is KHTRF’s Williams % R (14)?
KHTRF’s Williams % R (14) is -31.67, which suggests KHTRF is a Buy.
What is KHTRF’s CCI (14)?
KHTRF’s CCI (14) is 124.07, which suggests KHTRF is a Sell.

